ClinicalTrials.gg
Not yet recruitingNCT07825844Updated Sep 17, 2026

Tools for Return of Facial Function

An interventional study of Intraoral Stretching Splints in Facial Scarring, Facial Trauma and Burn, sponsored by The University of Texas Medical Branch, Galveston. Not yet recruiting at 1 site in United States. Open to participants aged 7 Years to 100 Years. Per ClinicalTrials.gov, last updated 2026-09-17.

Sponsored by The University of Texas Medical Branch, Galveston · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Not applicable
Ages
7 Years to 100 Years
Sex
All
01

Study summary

This study will evaluate novel intraoral (inside-the-mouth) splints designed to gently stretch facial tissues that have become tight or scarred following facial trauma, including burn injuries and gunshot wounds. Scar contractures can limit mouth opening, facial movement, and facial expressions, affecting daily function and quality of life.

Participants aged 7 years and older with facial contractures will be fitted with one or more silicone splints selected by a trained speech-language pathologist based on each participant's areas of restriction. The splints are available in different shapes and sizes and are designed to provide passive stretching to targeted areas of the face and mouth.

Researchers will assess changes in facial mobility, mouth opening, facial symmetry, and range of facial expression using clinical measurements and facial movement analysis software. The study will also help identify appropriate treatment protocols for use of the splints.

The researchers expect that use of the splints may improve facial movement and function, reduce the effects of scar contractures, and potentially decrease the need for future surgical procedures to improve facial mobility. Findings from this study may support a new treatment option for individuals with facial scarring due to burns or other traumatic injuries.

02

Conditions studied

  • Facial Scarring
  • Facial Trauma
  • Burn
  • Orofacial Contracture
  • Facial Scar Contracture

Browse trials for

03

In context

Burns

905 studies on the registry are indexed under Burns; 164 are open to participants now.

This study's planned enrollment of 50 is above the median of 40 across 663 interventional studies indexed under Burns.

Browse Burns studies →

Lead sponsor

The University of Texas Medical Branch, Galveston is the lead sponsor of 257 studies on the registry; 38 are open to participants now.

Of its 32 completed or terminated interventional studies of FDA-regulated products, 26 (81%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
7 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 7-100
  • Male or Female Sex
  • Patients who have sustained facial trauma, facial injury or a facial burn and are now in the chronic phase
  • Chief complaint(s) of limited mouth opening, difficulty chewing or speaking, decreased range of motion for oral structures, and/or limited facial expressions
  • Subject or caregiver (parent or guardian, in case of pediatric population) must be able to give
  • Subject or caregiver (parent or guardian, in case of pediatric population) must be able to perform exercises at home and must be able to record time spent using the splints
  • Participants who are undergoing other treatment methods such as facial surgeries, use of compression garments, skin grafting, etc., must suspend all these treatments for the duration of the 8-week trial
  • Access to internet and smartphone or computer capable of taking screenshots and with adequate audio and video capabilities (for those opting to participate via telehealth sessions

Exclusion criteria

Exclusion Criteria:

  • Planned or unplanned surgeries for facial skin grafting around lips or nose, or oral commissure release during the 8-week trial
  • Completion of any massaging or other stretching exercises or programs not specified by the investigators
  • Use of new creams or topical treatments for the duration of enrollment in the study
  • Acutely burn-injured patients
  • Incarceration or pregnancy
  • History of neurological deficit
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Intraoral Splint Therapy

    Participants with facial burns or other facial trauma resulting in orofacial contractures, scarring, fibrosis, or limited facial movement will receive individualized treatment using intraoral stretching splints. A trained speech-language pathologist will select the appropriate splint shape, size, and placement based on each participant's areas of facial restriction. Participants will use the prescribed splint or splints twice daily for approximately 60 minutes per session over an 8-week treatment period, with weekly assessments and adjustment of the treatment plan as needed.

    Device: Intraoral Stretching Splints

Interventions

  • DeviceIntraoral Stretching Splints

    A set of three silicone intraoral splints (ball, bar, and boomerang shapes) designed to provide passive stretching of scarred or contracted orofacial tissues. Splints are available in multiple sizes and may be used unilaterally or bilaterally to target specific areas of facial tightness and restricted movement.

06

What researchers measure

Primary outcomes

  1. Change in Facial Landmark Excursion

    Change from baseline in excursion (millimeters) between predefined facial landmarks during standardized facial expressions (rest, nose wrinkle, broad smile, lip pucker, and maximum mouth opening), measured using customized facial measurement software.

    Time frame: Baseline to Week 8

Secondary outcomes

  1. Change in Vertical Range of Mouth Opening (VROM)

    Change from baseline in maximum vertical mouth opening measured in millimeters using a digital caliper.

    Time frame: Baseline to Week 8

  2. Change in Horizontal Range of Mouth Opening (HROM)

    Change from baseline in maximum horizontal mouth opening measured in millimeters using a digital caliper.

    Time frame: Baseline to Week 8

  3. Change in Mouth Impairment and Disability Assessment (MIDA) Score

    Change from baseline in functional impairment and disability related to oral function as measured by the Mouth Impairment and Disability Assessment (MIDA). The MIDA includes patient-reported and clinician-assessed measures of symptoms, impairment, and functional activities.

    Time frame: Baseline and Week 8

  4. Change in CARe Burn Scale Score

    Change from baseline in burn-specific quality of life as measured by the age-appropriate CARe Burn Scale questionnaire.

    Time frame: Baseline and Week 8

07

Study locations

1 site
08

References and documents

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Dec 2026; primary completion for Mar 2028, 15 months later.

Of 210 non-industry interventional studies with no phase under Burns, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 38. This study's planned 15 months is below that.

Counting every sponsor, half of 239 studies reached it within 15 months; a quarter within 6 and three quarters within 38.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 11, 2026
First posted
Sep 17, 2026
StartEst.
Dec 2026
Primary completionEst.
Mar 2028
CompletionEst.
Aug 2028
Last update
Sep 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07825844
Responsible party
Sponsor
First posted
Sep 17, 2026
Start date
Dec 2026 (estimated)
Primary completion
Mar 2028 (estimated)
Completion
Aug 2028 (estimated)
Last update
Sep 17, 2026

Study contacts

Kathleen Kerr, MS
Contact
kmkerr@UTMB.EDU
409-772-2711

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion